Bill > H2212

This bill amends existing law to require healthcare practitioners to have a comprehensive discussion with patients (or their parents/guardians if the patient is under 18) before issuing the initial and third prescriptions for Schedule II controlled dangerous substances or opioid pain relievers. The discussion must cover specific risks, including addiction, overdose potential, dangers of mixing opioids with alcohol or other central nervous system depressants, reasons for the prescription's necessity, and available alternative treatments. Practitioners must also explain the risks of developing physical or psychological dependence and document this discussion in the patient's medical record. The bill provides important patient safety protections by mandating these detailed risk conversations, with notable exceptions for patients in cancer treatment, hospice care, long-term care facilities, or those receiving medication for substance abuse treatment. By requiring practitioners to explicitly discuss potential risks and alternatives, the bill aims to increase patient awareness and potentially reduce opioid misuse and addiction.

Health and Social Services

https://malegislature.gov/Bills/194/H2212